Dashboard
Manage Tickers

AKTXAkari Therapeutics Plc

Nasdaq akaritx.com


$ 1.44 $ -0.11 (-7.48 %)    

Friday, 03-May-2024 13:59:39 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 1.36
$ 1.44
$ 0.00 x 0
$ 0.00 x 0
$ 1.44 - $ 1.44
$ 1.08 - $ 5.50
20,772
na
13.31B
$ 0.98
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 05-12-2016 03-31-2016 10-Q
3 03-23-2016 12-31-2015 10-K
4 11-23-2015 09-30-2015 10-Q
5 08-12-2015 06-30-2015 10-Q
6 05-12-2015 03-31-2015 10-Q
7 02-11-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Akari Therapeutics And Peak Bio Announce P...
05/01/2024 12:08:56

Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a...

akari-therapeutics-appoints-samir-patel-as-interim-ceo
Akari Therapeutics Appoints Samir Patel As...
05/01/2024 12:05:20

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

akari-therapeutics-to-present-pas-nomacopan-pre-clinical-electroretinography-data-at-arvo-2024
Akari Therapeutics To Present PAS-Nomacopa...
04/15/2024 12:07:32

akari-therapeutics-cash-of-approximately-38m-as-of-december-31-2023-in-march-2024-it-raised-approximately-2m-via-private-placement-and-is-planning-to-secure-additional-capital-in-q2-of-2024
Akari Therapeutics' Cash Of Approximately ...
04/01/2024 10:35:00

akari-therapeutics-fy2023-eps-000-same-yoy
Akari Therapeutics FY2023 EPS $0.00, Same YoY
04/01/2024 10:34:00

Core News & Articles
Akari Therapeutics And Peak Bio Announce M...
03/05/2024 13:03:41

akari-therapeutics--closes-private-placement-with-existing-investors-for-gross-proceeds-of-2m
Akari Therapeutics Closes Private Placeme...
01/02/2024 13:01:01

akari-therapeutics-presents-poster-on-progress-in-pre-clinical-development-of-long-acting-pas-nomacopan-as-a-potential-treatment-for-geographic-atrophy-at-the-4th-annual-dry-amd-therapeutic-development-conference
Akari Therapeutics Presents Poster On Prog...
11/16/2023 13:18:26

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and infl...

akari-therapeutics-to-present-a-poster-on-pre-clinical-development-of-long-acting-pas-nomacopan-as-a-potential-treatment-for-geographic-atrophy-at-the-4th-annual-dry-amd-therapeutic-development-conference
Akari Therapeutics To Present A Poster On ...
11/06/2023 13:49:06

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and infl...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
10/30/2023 21:31:09

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
10/13/2023 13:06:02

akari-therapeutics-h1-2023-net-loss-of-299m-versus-108m-a-year-ago-cash-balance-of-approximately-72m-sufficient-to-fund-operations-into-q1-of-2024
Akari Therapeutics H1 2023 Net Loss Of $2....
09/29/2023 12:04:12

Akari Therapeutics (NASDAQ:AKTX) will report on H1 2023.

akari-therapeutics-announces-existing-investors-support-the-company-through-a-2m-private-placement-financing-company-also-receives-25m-uk-rd-tax-credit
Akari Therapeutics Announces Existing Inve...
09/21/2023 12:22:20

Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a late-stage biotechnology company developing...

akari-therapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement
Akari Therapeutics Regains Compliance With...
09/05/2023 12:19:16

 Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inf...

akari-therapeutics-announces-establishment-of-boston-us-headquarters-office-to-support-expanding-operations-and-start-of-registrational-phase-3-clinical-trials
Akari Therapeutics Announces Establishment...
08/18/2023 12:02:59

why-nice-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why NICE Are Trading Lower By Around 10%? ...
08/17/2023 16:26:44

Gainers PhenomeX Inc. (NASDAQ: CELL) shares surged 138.3% to $0.9532. Bruker Corporation and PhenomeX reported a $108 millio...

akari-therapeutics-plc-american-depositary-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--15
Akari Therapeutics Plc American Depositary...
08/17/2023 14:25:33

akari-therapeutics-plc-american-depositary-shares-resume-trade
Akari Therapeutics Plc American Depositary...
08/17/2023 14:23:26

akari-therapeutics-plc-american-depositary-shares-halted-on-circuit-breaker-to-the-upside-stock-now-down--916
Akari Therapeutics Plc American Depositary...
08/17/2023 14:14:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION